PubRank

B Gruhn

Author PubWeight™ 30.92‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 New insights to the MLL recombinome of acute leukemias. Leukemia 2009 4.07
2 Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention. Bone Marrow Transplant 2004 1.84
3 Posaconazole salvage treatment in paediatric patients: a multicentre survey. Eur J Clin Microbiol Infect Dis 2010 1.60
4 Reverse mosaicism in Fanconi anemia: natural gene therapy via molecular self-correction. Cytogenet Genome Res 2002 1.49
5 MicroRNA expression profiles of trophoblastic cells. Placenta 2012 1.18
6 Standardization of WT1 mRNA quantitation for minimal residual disease monitoring in childhood AML and implications of WT1 gene mutations: a European multicenter study. Leukemia 2009 0.96
7 Stable and reproducible engraftment of primary adult and pediatric acute myeloid leukemia in NSG mice. Leukemia 2011 0.94
8 Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective. Bone Marrow Transplant 2004 0.94
9 Comparison of six different specimen types for Epstein-Barr viral load quantification in peripheral blood of pediatric patients after heart transplantation or after allogeneic hematopoietic stem cell transplantation. J Clin Virol 2011 0.88
10 No improvement of survival with reduced- versus high-intensity conditioning for allogeneic stem cell transplants in Ewing tumor patients. Ann Oncol 2011 0.88
11 Procalcitonin, C-reactive protein, and endotoxin after bone marrow transplantation: identification of children at high risk of morbidity and mortality from sepsis. Bone Marrow Transplant 2003 0.88
12 A somatic EZH2 mutation in childhood acute myeloid leukemia. Leukemia 2012 0.87
13 Tandem application of flow cytometry and polymerase chain reaction for comprehensive detection of minimal residual disease in childhood acute lymphoblastic leukemia. Leukemia 1999 0.86
14 Key treatment questions in childhood acute lymphoblastic leukemia: results in 5 consecutive trials performed by the ALL-BFM study group from 1981 to 2000. Klin Padiatr 2013 0.86
15 Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European Group for Blood and Marrow Transplantation registry. Lupus 2012 0.86
16 Allo-SCT using BU, CY and melphalan for children with AML in second CR. Bone Marrow Transplant 2012 0.85
17 Long-term follow-up of children conditioned with Treosulfan: German and Austrian experience. Bone Marrow Transplant 2012 0.85
18 Elevated serum insulin-like growth factor binding protein-2 is associated with a high relapse risk after hematopoietic stem cell transplantation in childhood AML. Bone Marrow Transplant 2006 0.85
19 Semiquantitative PCR analysis of Epstein-Barr virus DNA in clinical samples of patients with EBV-associated diseases. J Med Virol 2001 0.83
20 Allogeneic blood SCT for children with Hurler's syndrome: results from the German multicenter approach MPS-HCT 2005. Bone Marrow Transplant 2008 0.83
21 Clinical relevance of serial quantitative analysis of hematopoietic chimerism after allogeneic stem cell transplantation in children for severe aplastic anemia. Bone Marrow Transplant 2004 0.83
22 Real-time PCR quantification of major Wilms' tumor gene 1 (WT1) isoforms in acute myeloid leukemia, their characteristic expression patterns and possible functional consequences. Leukemia 2012 0.82
23 High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma. Bone Marrow Transplant 2002 0.82
24 Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessment. Br J Cancer 2013 0.82
25 Neuroblastoma cells can express the hematopoietic progenitor cell antigen CD34 as detected at surface protein and mRNA level. J Neuroimmunol 1999 0.81
26 Immune response of varicella vaccinees to different varicella-zoster virus genotypes. Vaccine 2011 0.80
27 T-cell independent production of salivary secretory IgA after hematopoietic stem cell transplantation in children. Oral Microbiol Immunol 2005 0.79
28 Expression of CD34 and other haematopoietic antigens on neuroblastoma cells: consequences for autologous bone marrow and peripheral blood stem cell transplantation. J Neuroimmunol 1997 0.78
29 Human leukocyte antigen distribution in German Caucasians with advanced Ewing's sarcoma. Klin Padiatr 2012 0.76
30 Multiple viral infections after haploidentical hematopoietic stem cell transplantation in a child with acute lymphoblastic leukemia. Transpl Infect Dis 2012 0.75
31 [Lymphadenitits caused by nontuberculous mycobacteria]. Rofo 2004 0.75
32 Anticoagulation with recombinant hirudin following bone marrow transplantation in a patient with activated protein C resistance and heparin-induced antibodies showing cross-reactivity to the heparinoid danaparoid. Med Pediatr Oncol 1999 0.75
33 [MRI screening before stem cell transplantation--necessary?]. Rofo 2007 0.75
34 [Hemolytic-uremic syndrome in childhood]. Kinderarztl Prax 1988 0.75
35 Acute lymphoblastic leukemia in a 10-year-old boy with cystic fibrosis - improvement of pulmonary function during chemotherapy in spite of intermittent Pseudomonas aeruginosa colonisation. Klin Padiatr 2011 0.75
36 [Heparin-induced type II thrombocytopenia within the scope of high dose chemotherapy with subsequent stem cell rescue]. Klin Padiatr 1998 0.75